Electrophysiological and clinical correlates of corpus callosum atrophy in patients with multiple sclerosis

References

• Bruck W. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J Neurol 2005; 252 (Suppl. 5): v10—v15
   Google Scholar
• Lassmann H. The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1635–1640
   PubMed Web of Science ®Google Scholar
• Lassmann H, Bruck W, Lucchinetti CF, et al. The immunopathol-ogy of multiple sclerosis: An overview. Brain Pathol 2007; 17: 210–218
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiplesclerosis lesions: Implications for the pathogenesis of demyelina-tion. Ann Neurol 2000; 47: 707–717.
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin 2005; 23: 77–105
   PubMed Web of Science ®Google Scholar
• Jokinen H, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: The LADIS Study. J Neurol Neurosurg Psychiatry 2007; 78: 491–496
   PubMed Web of Science ®Google Scholar
• Nauta II, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs. J Neurol Sci 1994; 122: 6–14
   PubMed Web of Science ®Google Scholar
• Fierro B, Salemi G, Brighina F, et al. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 2002; 105: 152–157
   PubMed Web of Science ®Google Scholar
• Fuhr P, Kappos L. Evoked potentials for evaluation of multiplesclerosis. Clin Neurophysiol 2001; 112: 2185–2189
   PubMed Web of Science ®Google Scholar
• Leocani L, Rovaris M, Boneschi FM, et al. Multimodal evoked potentials to assess the evolution of multiple sclerosis: A long-itudinal study. J Neurol Neurosurg Psychiatry 2006; 77: 1030–1035
   PubMed Web of Science ®Google Scholar
• Audoin B, Ibarrola D, Malikova I, et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis — a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler 2007; 13: 41–51
   PubMed Web of Science ®Google Scholar
• Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: Sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992; 159: 1041–1047
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121–127
   PubMed Web of Science ®Google Scholar
• Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler 2008; 14: 1157–1174
   PubMed Web of Science ®Google Scholar
• Paty DW, Oger ii, Kastrukoff LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180–185
   PubMed Web of Science ®Google Scholar
• Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452
   PubMed Web of Science ®Google Scholar
• Paolillo A, Pozzilli C, Gasperini C, et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability. J Neurol Sci 2000; 174: 85–91
   PubMed Web of Science ®Google Scholar
• Pelletier J, Suchet L, Witjas T, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing—remitting multiple sclerosis. Arch Neurol 2001; 58: 105–111
   PubMed Web of Science ®Google Scholar
• Simon JH, Jacobs LD, Campion MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999; 53: 139–148
   PubMed Web of Science ®Google Scholar
• Furby J, Hayton T, Anderson V, et al. Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult Scler 2008; 14: 1068–1075
   PubMed Web of Science ®Google Scholar
• Barkhof FJ, Elton M, Lindeboom J, et al. Functional correlates of callosal atrophy in relapsing—remitting multiple sclerosis patients. A preliminary MRI study. J Neurol 1998; 245: 153–158
   PubMed Web of Science ®Google Scholar
• Figueira FF, Santos VS, Figueira GM, et al. Corpus callosum index: A practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr 2007; 65: 931–935
   PubMed Web of Science ®Google Scholar
• Rashid W, Davies GR, Chard DT, et al. Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing—remitting multiple sclerosis: A two-year long-itudinal study. Mult Scler 2007; 13: 178–185
   PubMed Web of Science ®Google Scholar
• Oh J, Henry RG, Genain C, et al. Mechanisms of normal appearing corpus callosum injury related to pericallosal Ti lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 2004; 75: 1281–1286
   PubMed Web of Science ®Google Scholar
• Kidd D, Thompson PD, Day BL, et al. Central motor conduction time in progressive multiple sclerosis. Correlations with MRI and disease activity. Brain 1998; 121: 1109–1116
   PubMed Web of Science ®Google Scholar
• Kjaer M. Evoked potentials. With special reference to the diagnostic value in multiple sclerosis. Acta Neurol Scand 1983; 67: 67–89
   PubMed Web of Science ®Google Scholar
• Sahota P, Prabhakar S, Lal V, et al. Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis. Neurol India 2005; 53: 197–201
   PubMedGoogle Scholar